Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus

Table 1

Clinical characteristics of study subjects.

Age (years)	64.7±11.5
Sex (male/female)	115/18
BMI (kg/m^2)	25.6±4.5
Disease duration (years)	18.3±10.5
Hypertension (%)	85.0
Dyslipidemia (%)	76.7
Smoking (%)	27.1
FPG (mmol/L)	9.6±3.1
HbA1c (%)	8.1±1.6
Total cholesterol (mmol/L)	4.8±0.8
HDL cholesterol (mmol/L)	1.3±0.4
Triglyceride (mmol/L)	1.7±1.0
Plasma creatinine (mmol/L)	183±206
eGFR (mL/min/1.73 m^2)	50.4±29.1
25(OH)D (ng/mL)	71.2±22.3
VDBP (mg/dL)	31.7±39.1
hs-CRP (mg/dL)	0.19±0.61
WBC (mm^3)	7091±2058
Retinopathy; (none/simple/proliferative)	51/53/29
Nephropathy; (none/microalbuminuria/macroalbuminuria/CRF/dialysis)	23/40/31/31/8
History of cardiovascular disease (%)	32.3

Continuous variables are expressed as mean ± SD. FPG: fasting plasma glucose, eGFR: estimated glomerular filtration rate, 25(OH)D: 25-hydroxyvitamin D, VDBP: vitamin D binding protein, hs-CRP: high sensitive C-reactive protein, WBC: white blood cell count, and CRF: chronic renal failure.